FemiLift (FDA) – Dr. Madeline Tarrillion
U.S. Food and Drug Administration (FDA) Clearance of CO2 lasers: Genitourinary syndrome of menopause (GSM), previously known as vulvovaginal atrophy (VVA), is a condition affecting postmenopausal women, which usually includes vaginal dryness, burning, itching, irritation, urinary incontinence, dysuria (pain with urination) and dyspareunia (pain with sexual activity). Standard therapies include vaginal moisturizers, low dose topical… Read More »
- Posted on: Oct 15 2018